Patent details
LUC00115 Product Name: An antibody comprising a VH sequence of EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYIMMWVRQAPGKGLEWVSGIYSSGGITVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVPRRDEFDIWGQGTMVTVSS and a VL sequence of DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYWTFGQGTKVEIK in particular lanadelumab.
Basic Information
- Publication number:
- LUC00115
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP117321455
- Legal Status:
- Inactive
- Application number:
- LUC00115
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1340
- Marketing Authorization Type:
- Marketing Authorization Date:
- 26/11/2018
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 18/04/2019
- First Marketing Authorization date:
- 26/11/2018
- Grant date:
- 22/05/2024
- Activation date:
- Publication date:
- 24/04/2019
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 26/11/2033
- SPC Extension Expiration:
- 26/11/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 21/06/2021
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)
History of Owners
- From:
- 18/04/2019
- To:
- 21/06/2021
- Name:
- Dyax Corp.
- Address:
- 300 Shire Way, Lexington, MA 02421, United States (US)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 18/04/2019
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2019/06
- Publication date:
- 06/05/2019
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2021/08
- Publication date:
- 01/07/2021
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/07
- Publication date:
- 03/06/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20210000252A
- Date Registered:
- 21/06/2021
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- Baker & McKenzie
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/01/2031
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/04/2019 | General Document | 1 |
| 18/04/2019 | General Document | 1 |
| 18/04/2019 | General Document | 1 |
| 21/06/2021 | Request For Change | 6 |
| 18/04/2019 | General Document | 4 |
| 18/04/2019 | General Document | 68 |
| 24/04/2019 | Outgoing Correspondence | 2 |
| 18/04/2019 | Application Form | 5 |
| 22/06/2021 | Outgoing Correspondence | 2 |
| 18/04/2019 | General Document | 32 |
| 23/05/2024 | Outgoing Correspondence | 1 |
| 22/05/2024 | Publication | 1 |
| 22/05/2024 | Certificate | 1 |
| 24/04/2019 | Publication | 1 |